Ligand Pharmaceuticals Inc

LGNDNASDAQ · US

Holders

REDUCEDT+7
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
−235 sh · $72.2K
Filed 6 Oct 2026SEC Form 4view source
REDUCEDT+7
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
−1,535 sh · $467.4K
Filed 6 Oct 2026SEC Form 4view source
REDUCEDT+7
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
−1,976 sh · $599.8K
Filed 6 Oct 2026SEC Form 4view source
ACQUIREDT+7
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
+340 sh · $17.8K
Filed 6 Oct 2026SEC Form 4view source
REDUCEDT+7
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
−17 sh · $5.2K
Filed 6 Oct 2026SEC Form 4view source
REDUCEDT+7
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
−833 sh · $252.0K
Filed 6 Oct 2026SEC Form 4view source
REDUCEDT+7
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
−404 sh · $123.7K
Filed 6 Oct 2026SEC Form 4view source
REDUCEDT+30
Zimmermann Martine
Ligand Pharmaceuticals Inc · NASDAQ
−115 sh · $34.3K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Zimmermann Martine
Ligand Pharmaceuticals Inc · NASDAQ
−1,200 sh · $342.0K
Filed 14 Sept 2026SEC Form 4view source
REDUCEDStale
Reardon Andrew
Ligand Pharmaceuticals Inc · NASDAQ
−300 sh · $85.2K
Filed 8 Sept 2026SEC Form 4view source